26 Expand Access for GLP-1 Therapies: Many insurance plans, including Medicare, exclude coverage for GLP-1 products for obesity, leaving millions of Americans who could benefit from these treatments without affordable access
From this model, it is estimated that as a result of the competition with icodec for albumin binding locally at the injection site, less than 1% of semaglutide is bound to albumin in the subcutis following IcoSema administration (Alifrangis L., 2025, unpublished data)
Ideal Candidates Adults with significant weight to lose represent the primary target population for this combination
Oral glutathione is poorly absorbed
"When the medical system doesn't know exactly what the best recommendation is people are smart
Building Tolerance Over Time After about four weeks, your body becomes familiar with the current dose